• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部进展期胃癌淋巴结转移的临床病理因素及列线图构建

Clinicopathological Factors and Nomogram Construction for Lymph Node Metastasis in Locally Advanced Gastric Cancer.

作者信息

Yu Zhiyuan, Liu Haopeng, Li Rui, Hu Liai, Xiao Chun, Gao Yunhe, Li Peiyu, Liang Wenquan, Zhou Sixin, Zhao Xudong

机构信息

Medical School of Chinese PLA, Beijing, People's Republic of China.

Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, People's Republic of China.

出版信息

Cancer Manag Res. 2024 Oct 18;16:1475-1489. doi: 10.2147/CMAR.S487247. eCollection 2024.

DOI:10.2147/CMAR.S487247
PMID:39439918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11495200/
Abstract

BACKGROUND

The research on lymph node metastasis (LNM) in locally advanced gastric cancer (LAGC) infiltrating the subserous tissue and serous membrane (T3-4a) is significantly inadequate. This study aims to explore the clinicopathological factors related to LNM in stages T3 and T4a LAGC, while also developing predictive nomograms.

METHODS

After systematic searching and rigorous screening, 1995 T3 and 1244 T4a LAGC cases who underwent surgery without neoadjuvant or perioperative chemotherapy were selected. The risk factors associated with LNM were identified using both univariate and multivariate logistic regression analyses. Subsequently, the independent variables identified through the multivariate analyses were utilized to construct a nomogram.

RESULTS

The incidence of LNM in T3 and T4a LAGC was 77.1% (1539/1995) and 83.8% (1043/1244), respectively. The following factors were found to be independently associated with LNM in T3 LAGC: preoperative serum albumin <41g/L (P=0.007), gastrointestinal obstruction (P<0.001), tumor location (P=0.040), tumor size >4cm (P=0.002), mixed (P=0.001) and undifferentiated histological types (P=0.002), presence of lymphovascular invasion (LVI) (P<0.001) and nerve invasion (P<0.001). Additionally, in T4a LAGC cases, serum albumin < 39g/L (P=0.004), tumor size >6cm (P=0.020), mixed (P<0.001) and undifferentiated histological types (P<0.001), presence of gastrointestinal hemorrhage (P=0.016), neuroendocrine differentiation (P=0.024), and LVI (P<0.001) independently influenced the occurrence of LNM.

CONCLUSION

This study identified the risk factors associated with LNM in T3-4a LAGC cases and constructed nomograms, thereby providing valuable guidance for formulating and implementing a multidisciplinary perioperative treatment program.

摘要

背景

关于浸润浆膜下组织和浆膜(T3 - 4a)的局部进展期胃癌(LAGC)淋巴结转移(LNM)的研究明显不足。本研究旨在探讨T3和T4a期LAGC中与LNM相关的临床病理因素,同时开发预测列线图。

方法

经过系统检索和严格筛选,选取1995例T3期和1244例T4a期未接受新辅助或围手术期化疗的LAGC手术病例。采用单因素和多因素逻辑回归分析确定与LNM相关的危险因素。随后,将多因素分析确定的自变量用于构建列线图。

结果

T3期和T4a期LAGC的LNM发生率分别为77.1%(1539/1995)和83.8%(1043/1244)。发现以下因素与T3期LAGC的LNM独立相关:术前血清白蛋白<41g/L(P = 0.007)、胃肠道梗阻(P<0.001)、肿瘤位置(P = 0.040)、肿瘤大小>4cm(P = 0.002)、混合型(P = 0.001)和未分化组织学类型(P = 0.002)、存在淋巴管侵犯(LVI)(P<0.001)和神经侵犯(P<0.001)。此外,在T4a期LAGC病例中,血清白蛋白<39g/L(P = 0.004)、肿瘤大小>6cm(P = 0.020)、混合型(P<0.001)和未分化组织学类型(P<0.001)、存在胃肠道出血(P = 0.016)、神经内分泌分化(P = 0.024)和LVI(P<0.001)独立影响LNM的发生。

结论

本研究确定了T3 - 4a期LAGC病例中与LNM相关的危险因素并构建了列线图,从而为制定和实施多学科围手术期治疗方案提供了有价值的指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b61e/11495200/465201edfea6/CMAR-16-1475-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b61e/11495200/834082cc1c97/CMAR-16-1475-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b61e/11495200/e4c4e1fead4d/CMAR-16-1475-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b61e/11495200/465201edfea6/CMAR-16-1475-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b61e/11495200/834082cc1c97/CMAR-16-1475-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b61e/11495200/e4c4e1fead4d/CMAR-16-1475-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b61e/11495200/465201edfea6/CMAR-16-1475-g0003.jpg

相似文献

1
Clinicopathological Factors and Nomogram Construction for Lymph Node Metastasis in Locally Advanced Gastric Cancer.局部进展期胃癌淋巴结转移的临床病理因素及列线图构建
Cancer Manag Res. 2024 Oct 18;16:1475-1489. doi: 10.2147/CMAR.S487247. eCollection 2024.
2
[A nomogram for predicting lymph node metastasis in early gastric cancer].[一种预测早期胃癌淋巴结转移的列线图]
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Jan 25;25(1):40-47. doi: 10.3760/cma.j.cn441530-20210208-00059.
3
Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study.深度学习放射组学列线图可预测局部进展期胃癌的淋巴结转移数目:一项国际多中心研究。
Ann Oncol. 2020 Jul;31(7):912-920. doi: 10.1016/j.annonc.2020.04.003. Epub 2020 Apr 15.
4
Clinicopathologic factors correlated with lymph node metastasis in gastric cancer: a retrospective cohort study involving 5606 patients.与胃癌淋巴结转移相关的临床病理因素:一项涉及 5606 例患者的回顾性队列研究。
J Gastrointest Surg. 2024 Aug;28(8):1242-1249. doi: 10.1016/j.gassur.2024.05.014. Epub 2024 May 12.
5
Risk factors of lymph node metastasis or lymphovascular invasion for superficial esophageal squamous cell carcinoma: A practical and effective predictive nomogram based on a cancer hospital data.食管浅表鳞状细胞癌淋巴结转移或淋巴管侵犯的危险因素:基于某癌症医院数据的实用且有效的预测列线图
Front Med (Lausanne). 2022 Nov 17;9:1038097. doi: 10.3389/fmed.2022.1038097. eCollection 2022.
6
A nomogram composed of clinicopathologic features and preoperative serum tumor markers to predict lymph node metastasis in early gastric cancer patients.由临床病理特征和术前血清肿瘤标志物组成的列线图,用于预测早期胃癌患者的淋巴结转移。
Oncotarget. 2016 Sep 13;7(37):59630-59639. doi: 10.18632/oncotarget.10732.
7
Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter data.早期胃癌淋巴结转移或淋巴管浸润的危险因素:基于国际多中心数据的实用有效预测模型。
BMC Cancer. 2019 Nov 6;19(1):1048. doi: 10.1186/s12885-019-6147-6.
8
The significance of preoperative serum carcinoembryonic antigen levels in the prediction of lymph node metastasis and prognosis in locally advanced gastric cancer: a retrospective analysis.术前血清癌胚抗原水平对局部进展期胃癌淋巴结转移及预后预测的意义:回顾性分析。
BMC Gastroenterol. 2020 Apr 10;20(1):100. doi: 10.1186/s12876-020-01255-6.
9
Risk Factors of Lymph Node Metastasis in Patients with Early Pure and Mixed Signet Ring Cell Gastric Carcinomas.早期单纯型和混合型印戒细胞胃癌患者淋巴结转移的危险因素
J Cancer. 2019 Jan 29;10(5):1124-1131. doi: 10.7150/jca.29245. eCollection 2019.
10
A practical nomogram included hyperlipidemia for predicting lymph node metastasis in patients with superficial esophageal squamous cell carcinoma.一个实用的列线图纳入了高血脂症,用于预测浅表性食管鳞癌患者的淋巴结转移。
Medicine (Baltimore). 2023 Nov 17;102(46):e35891. doi: 10.1097/MD.0000000000035891.

本文引用的文献

1
Clinicopathologic factors correlated with lymph node metastasis in gastric cancer: a retrospective cohort study involving 5606 patients.与胃癌淋巴结转移相关的临床病理因素:一项涉及 5606 例患者的回顾性队列研究。
J Gastrointest Surg. 2024 Aug;28(8):1242-1249. doi: 10.1016/j.gassur.2024.05.014. Epub 2024 May 12.
2
Risk Factor Analysis of Gastroparesis Syndrome in 2652 Patients with Radical Distal Gastrectomy.根治性远端胃大部切除术后 2652 例胃轻瘫综合征的危险因素分析。
J Gastrointest Surg. 2023 Aug;27(8):1568-1577. doi: 10.1007/s11605-022-05538-z. Epub 2023 May 1.
3
Early detection of gastric cancer in China: progress and opportunities.
中国胃癌的早期检测:进展与机遇。
Cancer Biol Med. 2022 Dec 12;19(12):1622-8. doi: 10.20892/j.issn.2095-3941.2022.0655.
4
Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition).日本胃癌治疗指南 2021(第 6 版)。
Gastric Cancer. 2023 Jan;26(1):1-25. doi: 10.1007/s10120-022-01331-8. Epub 2022 Nov 7.
5
Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients.空间代谢组学鉴定胃癌患者中独特的肿瘤特异性亚型。
Clin Cancer Res. 2022 Jul 1;28(13):2865-2877. doi: 10.1158/1078-0432.CCR-21-4383.
6
Surgical Management of Gastric Cancer: A Review.胃癌的外科治疗:综述
JAMA Surg. 2022 May 1;157(5):446-454. doi: 10.1001/jamasurg.2022.0182.
7
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.《胃癌,第2.2022版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南》
J Natl Compr Canc Netw. 2022 Feb;20(2):167-192. doi: 10.6004/jnccn.2022.0008.
8
nPTD classification: an updated classification of gastric cancer location for function preserving gastrectomy based on physiological lymphatic flow.nPTD 分类:基于生理学淋巴流向的保留胃功能胃癌切除术的胃癌位置更新分类。
BMC Cancer. 2021 Nov 17;21(1):1231. doi: 10.1186/s12885-021-08936-9.
9
Effectiveness and Safety of Apatinib Plus Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer: A Nonrandomized Controlled Trial.阿帕替尼联合化疗新辅助治疗局部晚期胃癌的有效性和安全性:一项非随机对照试验。
JAMA Netw Open. 2021 Jul 1;4(7):e2116240. doi: 10.1001/jamanetworkopen.2021.16240.
10
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021.中国临床肿瘤学会(CSCO):胃癌诊断与治疗临床诊疗指南,2021 年版。
Cancer Commun (Lond). 2021 Aug;41(8):747-795. doi: 10.1002/cac2.12193. Epub 2021 Jul 1.